Mechanisms of chemokine recognition and receptor activation of chemokine receptor CCR7
文献类型:期刊论文
| 作者 | Cao, Yinglong6; Zhang, Chao5; Yuan, Qingning3; Zhao, Fenghui4,6; Liu, Qiufeng2; Wu, Kai1; Hu, Wen1; He, Jin1; Li, Hongchun6; Xu, H. Eric1,7 |
| 刊名 | CELL REPORTS
![]() |
| 出版日期 | 2025-11-25 |
| 卷号 | 44期号:11页码:16 |
| ISSN号 | 2639-1856 |
| DOI | 10.1016/j.celrep.2025.116582 |
| 英文摘要 | The chemokine receptor C-C chemokine receptor (CCR7) is essential for immune cell trafficking, cancer metastasis, and autoimmune diseases, making it a significant therapeutic target. This study presents cryo-electron microscopy (cryo-EM) structures of CCR7-Gi complexes bound to CCL19 and CCL21, revealing detailed interactions between the receptor, the two chemokines, and the G alpha i protein. Key N-terminal residues and a conserved aromatic patch in the orthosteric pocket are crucial for receptor activation by both ligands, with CCL19 also establishing additional polar interactions that are critical for this process. Mutagenesis studies demonstrate that mutations in these residues result in variable effects on ligandinduced activation, emphasizing the distinct interaction modes of CCL19 and CCL21 with CCR7. Notably, we identify an interesting activation mechanism for CCR7, in which the conventional toggle switch residue W 6.48 is replaced by Q 6.48 , leading to distinctive conformational changes upon ligand binding. These insights enhance our understanding of G-protein-coupled receptor (GPCR) signaling diversity and lay the groundwork for future therapeutic interventions targeting CCR7. |
| WOS关键词 | STRUCTURAL BASIS ; MIGRATION ; LIGAND ; MODEL ; METASTASIS ; EXPRESSION ; IMMUNITY ; MEDULLA ; CELLS ; ELC |
| 资助项目 | National Natural Science Foundation of China[82373881] ; National Natural Science Foundation of China[32130022] ; National Natural Science Foundation of China[82121005] ; National Natural Science Foundation of China[82273985] ; National Natural Science Foundation of China[82473981] ; Young Elite Scientists Sponsorship Program by CAST[2022QNRC001] ; Shanghai Sailing Program[23YF1456800] ; Shanghai Sailing Program[22YF1457200] ; Youth Innovation Promotion Association of Chinese Academy of Sciences ; Lingang Laboratory[LG-8888] ; Lingang Laboratory[LG-GG-202204-01] ; CAS Strategic Priority Research Program[XDB37030103] ; CAS Strategic Priority Research Program[XDB1060402] ; Shanghai Municipal Science and Technology Major Project[2019SHZDZX02] ; National Key R&D Program of China[2022YFC2703105] ; National Key R&D Program of China[2023YFA1800804] ; National Research Center for Translational Medicine at Shanghai[NRCTM (SH) -2023-09] |
| WOS研究方向 | Cell Biology |
| 语种 | 英语 |
| WOS记录号 | WOS:001621945300001 |
| 出版者 | CELL PRESS |
| 源URL | [http://119.78.100.183/handle/2S10ELR8/322049] ![]() |
| 专题 | 国家级研究中心_原创新药研究全国重点实验室 |
| 通讯作者 | Xu, H. Eric; Yang, Dehua; Duan, Jia |
| 作者单位 | 1.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China 2.Shanghai Allist Pharmaceut Co Ltd, Shanghai, Peoples R China 3.Nanjing Univ Chinese Med, Coll Pharm, Nanjing 210023, Peoples R China 4.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Chem Biol, Shanghai 201203, Peoples R China 5.Fudan Univ, Sch Pharm, Shanghai 201203, Peoples R China 6.Chinese Acad Sci, Zhongshan Inst Drug Discovery, Shanghai Inst Mat Med, Zhongshan 528400, Peoples R China 7.ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China |
| 推荐引用方式 GB/T 7714 | Cao, Yinglong,Zhang, Chao,Yuan, Qingning,et al. Mechanisms of chemokine recognition and receptor activation of chemokine receptor CCR7[J]. CELL REPORTS,2025,44(11):16. |
| APA | Cao, Yinglong.,Zhang, Chao.,Yuan, Qingning.,Zhao, Fenghui.,Liu, Qiufeng.,...&Duan, Jia.(2025).Mechanisms of chemokine recognition and receptor activation of chemokine receptor CCR7.CELL REPORTS,44(11),16. |
| MLA | Cao, Yinglong,et al."Mechanisms of chemokine recognition and receptor activation of chemokine receptor CCR7".CELL REPORTS 44.11(2025):16. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。

